Skip to main content

Advertisement

SpringerLink
Log in

Comparative study of microRNA profiling in one Chinese Family with PSEN1 G378E mutation

  • Original Article
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

MicroRNAs are not widely studied in familial Alzheimer’s disease cases, whether the microRNA profilings in familial Alzheimer’s disease patients are similar to the sporadic AD patients is not known. This study aims to investigate the differential expression of microRNAs (miRNAs) associated with early-onset familial Alzheimer’s disease (EO-FAD) in a Chinese family. We performed the gene mutation analysis in a family clinically diagnosed of EO-FAD. Micro-arrays were used to profile the miRNAs in cerebrospinal fluid of 2 affected members, 2 unaffected carriers and 2 mutation negative controls. The clinical presentation confirmed the EO-FAD diagnosis, and a recurrent mutation of the PSEN1 p.G378E was found in the family. The result showed that in the miRNAs expression profile, a total of 166 miRNAs were up-regulated and 3 miRNAs were down-regulated in the affected individuals compared with mutation negative individuals. But after Benjamini Hochberg FDR correction, only 25 miRNAs were significantly up-regulated and no miRNA was down-regulated, the levels of miR-30a-5p, miR-4758-3p and let-7a-3p were elevated significantly. Compared with mutation negative controls, 21 miRNAs were up-regulated and 18 microRNAs were down-regulated in the unaffected mutation carriers, after Benjamini Hochberg FDR correction, miR-345-5p was up-regulated and miR-4795-3p was down-regulated in the unaffected mutation carriers. And there was no difference between the affected members and unaffected mutation carriers. GO database showed that the top biological processes affected by the predicted target genes are nucleic acid binding transcription factor activity and transcription factor activity (sequence-specific DNA binding) (GO:0001071 and GO:0003700). The result of KEGG pathways showed 64 pathways were implicated in the regulatory network. The present study identified the miRNA profiling of Chinese siblings with G378E mutation in the PSEN1. Compared with mutation negative controls, the levels of 25 miRNAs including miR-30a-5p, miR-4758-3p and let-7a-3p were elevated significantly in the affected members, miR-345-5p was up-regulated and miR-4795-3p was down-regulated in the unaffected mutation carriers. Our study showed the microRNA profilings in the cases of a EO-FAD family with PSEN1 p.G378E mutation, but because of the individuals in the family was small, the results in other types of EO-FAD still need further studied.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

miRNAs:

microRNAs

EO-FAD:

early-onset familial Alzheimer’s disease

MRI:

magnetic resonance imaging

AD:

Alzheimer’s disease

NFTs::

neurofibrillary tangles

CSF:

cerebrospinal fluid

SAD:

sporadic AD

FAD:

Familial AD

APP:

amyloid precursor protein

PSEN1:

presenilin 1

PSEN2:

presenilin 2

MMSE:

Mini- Mental State Examination

IADLs:

instrumental activities of daily living scales

FDR:

false discovery rate

TLR7:

toll-like receptor 7

KEGG:

Kyoto Encyclopedia of Genes and Genomes

NICD1:

Notch1 intercellular domain

References

  • Bekris LM, Leverenz JB (2015) The biomarker and therapeutic potential of miRNA in Alzheimer's disease. Neurodegener Dis Manag 5:61–74

    Article  PubMed  Google Scholar 

  • Besancon R, Lorenzi A, Cruts M, Radawiec S, Sturtz F, Broussolle E et al (1998) Missense mutation in exon 11 (codon 378) of the presenilin-1 gene in a French family with early-onset Alzheimer's disease and transmission study by mismatch enhanced allele specific amplification. Mutations in brief no. 141. Online. besancon@rockefeller1.univ.lyon1.fr. Hum Mutat 11:481

    Article  CAS  PubMed  Google Scholar 

  • Burgos K, Malenica I, Metpally R, Courtright A, Rakela B, Beach T, Shill H, Adler C, Sabbagh M, Villa S, Tembe W, Craig D, van Keuren-Jensen K (2014) Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology. PLoS One 9:e94839

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen PS, Su JL, Cha ST, Tarn WY, Wang MY, Hsu HC, Lin MT, Chu CY, Hua KT, Chen CN, Kuo TC, Chang KJ, Hsiao M, Chang YW, Chen JS, Yang PC, Kuo ML (2011) miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans. J Clin Invest 121:3442–3455

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cornejo-Olivas MR, Yu CE, Mazzetti P, Mata IF, Meza M, Lindo-Samanamud S, Leverenz JB, Bird TD (2014) Clinical and molecular studies reveal a PSEN1 mutation (L153V) in a Peruvian family with early-onset Alzheimer's disease. Neurosci Lett 563:140–143

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Croce N, Gelfo F, Ciotti MT, Federici G, Caltagirone C, Bernardini S, Angelucci F (2013 Apr) NPY modulates miR-30a-5p and BDNF in opposite direction in an in vitro model of Alzheimer disease: a possible role in neuroprotection? Mol Cell Biochem 376(1–2):189–195

    Article  CAS  PubMed  Google Scholar 

  • Dorszewska J, Prendecki M, Oczkowska A, Dezor M, Kozubski W (2016) Molecular basis of familial and sporadic Alzheimer's disease. Curr Alzheimer Res 13:952–963

    Article  CAS  PubMed  Google Scholar 

  • Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K et al (2014) Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. Lancet Neurol 13:614–629

    Article  PubMed  Google Scholar 

  • Erener S, Marwaha A, Tan R, Panagiotopoulos C, Kieffer TJ (2017 Feb 23) Profiling of circulating microRNAs in children with recent onset of type 1 diabetes. JCI Insight 2(4):e89656

    Article  PubMed  PubMed Central  Google Scholar 

  • Fernandez AM, Hervas R, Dominguez-Fraile M, Garrido VN, Gomez-Gutierrez P, Vega M, Vitorica J, Perez JJ, Torres Aleman I (2016 Apr 12) Blockade of the interaction of Calcineurin with FOXO in astrocytes protects against amyloid-β-induced neuronal death. J Alzheimers Dis 52(4):1471–1478

    Article  CAS  PubMed  Google Scholar 

  • Finckh U, Kuschel C, Anagnostouli M, Patsouris E, Pantes GV, Gatzonis S, Kapaki E, Davaki P, Lamszus K, Stavrou D, Gal A (2005) Novel mutations and repeated findings of mutations in familial Alzheimer disease. Neurogenetics 6:85–89

    Article  CAS  PubMed  Google Scholar 

  • Gui Y, Liu H, Zhang L, Lv W, Hu X (2015) Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease. Oncotarget 6:37043–37053

    Article  PubMed  PubMed Central  Google Scholar 

  • Guo Y, Sun W, Gong T, Chai Y, Wang J, Hui B et al (2017 Feb 14) miR-30a radiosensitizes non-small cell lung cancer by targeting ATF1 that is involved in the phosphorylation of ATM. Oncol Rep

  • Han X, Zhen S, Ye Z, Lu J, Wang L, Li P, Li J, Zheng X, Li H, Chen W, Zhao L, Li X (2017 Feb 21) A feedback loop between miR-30a/c-5p and DNMT1 mediates cisplatin resistance in ovarian Cancer cells. Cell Physiol Biochem 41(3):973–986

    Article  CAS  PubMed  Google Scholar 

  • Hebert SS, Horre K, Nicolai L, Papadopoulou AS, Mandemakers W, Silahtaroglu AN, Kauppinen S, Delacourte A, de Strooper B (2008) Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci U S A 105:6415–6420

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ikeuchi T, Kaneko H, Miyashita A, Nozaki H, Kasuga K, Tsukie T, Tsuchiya M, Imamura T, Ishizu H, Aoki K, Ishikawa A, Onodera O, Kuwano R, Nishizawa M (2008) Mutational analysis in early-onset familial dementia in the Japanese population. The role of PSEN1 and MAPT R406W mutations. Dement Geriatr Cogn Disord 26:43–49

    Article  CAS  PubMed  Google Scholar 

  • Jayadev S, Case A, Alajajian B, Eastman AJ, Moller T, Garden GA (2013) Presenilin 2 influences miR146 level and activity in microglia. J Neurochem 127:592–599

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kiko T, Nakagawa K, Tsuduki T, Furukawa K, Arai H, Miyazawa T (2014) MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer's disease. J Alzheimers Dis 39:253–259

    Article  CAS  PubMed  Google Scholar 

  • Lehmann SM, Kruger C, Park B, Derkow K, Rosenberger K, Baumgart J et al (2012) An unconventional role for miRNA: let-7 activates toll-like receptor 7 and causes neurodegeneration. Nat Neurosci 15:827–835

    Article  CAS  PubMed  Google Scholar 

  • Lei X, Lei L, Zhang Z, Zhang Z, Cheng Y (2015) Downregulated miR-29c correlates with increased BACE1 expression in sporadic Alzheimer's disease. Int J Clin Exp Pathol 8:1565–1574

    CAS  PubMed  PubMed Central  Google Scholar 

  • Li Y, Zhang T, Zhou Y, Sun Y, Cao Y, Chang X, Zhu Y, Han X (2016 Nov 2) A Presenilin/Notch1 pathway regulated by miR-375, miR-30a, and miR-34a mediates glucotoxicity induced-pancreatic beta cell apoptosis. Sci Rep 6:36136

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lukiw WJ, Andreeva TV, Grigorenko AP, Rogaev EI (2012) Studying micro RNA function and dysfunction in Alzheimer's disease. Front Genet 3:327

    Article  PubMed  Google Scholar 

  • Luo H, Wu Q, Ye X, Xiong Y, Zhu J, Xu J, Diao Y, Zhang D, Wang M, Qiu J, Miao J, Zhang W, Wan J (2014 Aug 22) Genome-wide analysis of miRNA signature in the APPswe/PS1ΔE9 mouse model of alzheimer'sdisease. PLoS One 9(8):e101725

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lv Z, Shi Q, Huang W, Xing C, Hao Y, Feng X et al (2016) MicroRNA expression profiling in Guillain-Barré syndrome. J Neuroimmunol 301:12–15

    Article  CAS  PubMed  Google Scholar 

  • Maiese K (2015) FoxO proteins in the nervous system. Anal Cell Pathol (Amst) 2015:569392

    Google Scholar 

  • Manolopoulos KN, Klotz LO, Korsten P, Bornstein SR, Barthel A (2010 Nov) Linking Alzheimer's disease to insulin resistance: the FoxO response to oxidative stress. Mol Psychiatry 15(11):1046–1052

    Article  CAS  PubMed  Google Scholar 

  • Mellios N, Huang HS, Grigorenko A, Rogaev E, Akbarian S (2008 Oct 1) A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitorsof BDNF in prefrontal cortex. Hum Mol Genet 17(19):3030–3042

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Meng F, Wang F, Wang L, Wong SC, Cho WC, Chan LW (2016 Nov 15) MiR-30a-5p overexpression may overcome EGFR-inhibitor resistance through regulating PI3K/AKT signaling pathway in non-small cell lung Cancer cell lines. Front Genet 7:197

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Muller M, Kuiperij HB, Claassen JA, Kusters B, Verbeek MM (2014) MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid. Neurobiol Aging 35:152–158

    Article  CAS  PubMed  Google Scholar 

  • Pan Y, Liu R, Terpstra E, Wang Y, Qiao F, Wang J, Tong Y, Pan B (2015) Dysregulation and diagnostic potential of microRNA in Alzheimer's disease. J Alzheimers Dis 49:1–12

    Article  CAS  Google Scholar 

  • Park CK, Xu ZZ, Berta T, Han Q, Chen G, Liu XJ, Ji RR (2014) Extracellular microRNAs activate nociceptor neurons to elicit pain via TLR7 and TRPA1. Neuron 82:47–54

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pugazhenthi S (2017) Metabolic syndrome and the cellular phase of Alzheimer's disease. Prog Mol Biol Transl Sci 146:243–258

    Article  CAS  PubMed  Google Scholar 

  • Quanquan W, Yanlei H, Yan Y, Qingxia K, Shuhu Z, Zhanyun L (2017 march) A Chinese pedigree with early-onset familial Alzheimer’s disease caused by presenilin 1 p.G378E. Chin J Neurol 50(3):208–212

    Google Scholar 

  • Ren RJ, Zhang YF, Dammer EB, Zhou Y, Wang LL, Liu XH, Feng BL, Jiang GX, Chen SD, Wang G, Cheng Q (2016) Peripheral blood MicroRNA expression profiles in Alzheimer's disease: screening, validation, association with clinical phenotype and implications for molecular mechanism. Mol Neurobiol 53:5772–5781

    Article  CAS  PubMed  Google Scholar 

  • Sajan M, Hansen B, Ivey R. 3rd, Sajan J, Ari C, Song S, et al. Brain insulin signaling is increased in insulin-resistant states and decreases in FOXOs and PGC-1α and increases in Aβ1-40/42 and Phospho-tau may abet Alzheimer development. Diabetes 2016 Jul;65(7):1892–1903

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Satoh J, Kino Y, Niida S (2015) MicroRNA-Seq data analysis pipeline to identify blood biomarkers for Alzheimer's disease from public data. Biomark Insights 10:21–31

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shafi O (2016 Nov 22) Inverse relationship between Alzheimer's disease and cancer, and other factors contributing toAlzheimer's disease: a systematic review. BMC Neurol 16(1):236

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shamsuzzama KL, Haque R, Nazir A (2016) Role of MicroRNA Let-7 in modulating multifactorial aspect of neurodegenerative diseases: an overview. Mol Neurobiol 53:2787–2793

    Article  CAS  PubMed  Google Scholar 

  • Song J, Lee JE (2015) miR-155 is involved in Alzheimer's disease by regulating T lymphocyte function. Front Aging Neurosci 7:61

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sorensen SS, Nygaard AB, Christensen T (2016) miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer's disease and other types of dementia - an exploratory study. Transl Neurodegener 5:6

    Article  PubMed  PubMed Central  Google Scholar 

  • Tai LM, Mehra S, Shete V, Estus S, Rebeck GW, Bu G, LaDu M (2014) Soluble apoE/Abeta complex: mechanism and therapeutic target for APOE4-induced AD risk. Mol Neurodegener 9:2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tan L, Yu JT, Tan MS, Liu QY, Wang HF, Zhang W, Jiang T, Tan L (2014) Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease. J Alzheimers Dis 40:1017–1027

    Article  CAS  PubMed  Google Scholar 

  • Van Giau V, An SS (2016) Emergence of exosomal miRNAs as a diagnostic biomarker for Alzheimer's disease. J Neurol Sci 360:141–152

    Article  CAS  PubMed  Google Scholar 

  • Wei W, Yang Y, Cai J, Cui K, Li RX, Wang H et al (2016) MiR-30a-5p suppresses tumor metastasis of human colorectal Cancer by targeting ITGB3. Cell Physiol Biochem 39(3):1165–1176

    Article  CAS  PubMed  Google Scholar 

  • Zhao Y, Bhattacharjee S, Jones BM, Hill J, Dua P, Lukiw WJ (2014) Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer's disease (AD) and in primary human neuronal-glial (HNG) cells. Mol Neurobiol 50:97–106

    Article  CAS  PubMed  Google Scholar 

  • Zhao Y, Pogue AI, Lukiw WJ (2015) MicroRNA (miRNA) signaling in the human CNS in sporadic Alzheimer's disease (AD)-novel and unique pathological features. Int J Mol Sci 16:30105–30116

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhu J, Zeng Y, Li W, Qin H, Lei Z, Shen D, Gu D, Huang JA, Liu Z (2017 Feb 3) CD73/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer. Mol Cancer 16(1):34

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zong Y, Wang H, Dong W, Quan X, Zhu H, Xu Y, Huang L, Ma C, Qin C (2011) miR-29c regulates BACE1 protein expression. Brain Res 1395:108–115

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank the patients for their participation in this study.

Funding

This study was supported by the National Natural Science Foundation of China (grant No. 81401064, NO.81771360); PhD initial funding (2016-BS-011); Jining science and technology development project (Jikezi [2016]56–6) and Natural Science Foundation of Shandong (ZR2017LH031).

Author information

Authors and Affiliations

  1. Department of Neurology, Affiliated Hospital of Jining Medical University, No. 89 Guhuai Road, Jining, 272000, Shandong, China

    Zhanyun Lv, Liangchen Hu, Yan Yang, Kui Zhang, Zuzhen Sun, Jing Zhang, Lipan Zhang & Yanlei Hao

Authors
  1. Zhanyun Lv
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Liangchen Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yan Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kui Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zuzhen Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jing Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Lipan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yanlei Hao
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Lv ZY and Hu LC contributed equally in RNA extraction and microRNA analysis. Zhang K, Sun ZZ, Zhang J, Zhang LP and Yang Y interviewed the patients and their family members, collected clinical data and CSF and blood samples. Hao YL was a major contributor in writing the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Yanlei Hao.

Ethics declarations

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Written informed consent for publication was obtained from patients. A copy of the written consent is available for review to the Editor of this journal.

Ethics approval and consent to participate

The study protocol was approved by the Ethics Committees of the Affiliated Hospital of Jining Medical University, and all participants provided written informed consent.

Additional information

Zhanyun Lv and Liangchen Hu contribute equally to this paper and should be considered co-first authors.

Electronic supplementary material

ESM 1

(DOCX 27 kb)

ESM 2

(DOCX 38 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lv, Z., Hu, L., Yang, Y. et al. Comparative study of microRNA profiling in one Chinese Family with PSEN1 G378E mutation. Metab Brain Dis 33, 1711–1720 (2018). https://doi.org/10.1007/s11011-018-0279-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-018-0279-2

Keywords

Search

Navigation